Komrokji RS - Search Results

1

Hypoalbuminemia is an independent prognostic factor for overall survival in myelodysplastic syndromes.

Komrokji RS, Corrales-Yepez M, Kharfan-Dabaja MA, Al Ali NH, Padron E, Rollison DE, Pinilla-Ibarz J, Zhang L, Epling-Burnette PK, Lancet JE, List AF. Komrokji RS, et al. Am J Hematol. 2012 Nov;87(11):1006-9. doi: 10.1002/ajh.23303. Epub 2012 Aug 1. Am J Hematol. 2012. PMID: 23090887 Free article.

2

Burkitt's leukemia with precursor B-cell immunophenotype and atypical morphology (atypical Burkitt's leukemia/lymphoma): case report and review of literature.

Komrokji R, Lancet J, Felgar R, Wang N, Bennett JM. Komrokji R, et al. Leuk Res. 2003 Jun;27(6):561-6. doi: 10.1016/s0145-2126(02)00271-0. Leuk Res. 2003. PMID: 12648517 Review.

3

The myelodysplastic syndromes: classification and prognosis.

Komrokji R, Bennett JM. Komrokji R, et al. Curr Hematol Rep. 2003 May;2(3):179-85. Curr Hematol Rep. 2003. PMID: 12901338 Review.

4

Donor cell myelodysplastic syndrome after allogeneic stem cell transplantation responding to donor lymphocyte infusion: case report and literature review.

Komrokji R, Ifthikharuddin JJ, Felgar RE, Abboud CN, Wedow LA, Connaughton A, Bennett JM. Komrokji R, et al. Am J Hematol. 2004 Aug;76(4):389-94. doi: 10.1002/ajh.20111. Am J Hematol. 2004. PMID: 15282676 Free article. Review.

5

The clinical implications of the World Health Organization's classification of myelodysplastic syndromes.

Komrokji RS, Bennett JM. Komrokji RS, et al. Curr Hematol Rep. 2005 May;4(3):175-81. Curr Hematol Rep. 2005. PMID: 15865868 Review.

6

Evolving classifications of the myelodysplastic syndromes.

Komrokji RS, Bennett JM. Komrokji RS, et al. Curr Opin Hematol. 2007 Mar;14(2):98-105. doi: 10.1097/MOH.0b013e328017f633. Curr Opin Hematol. 2007. PMID: 17255786 Review.

7

Outcome of patients with myelodysplastic syndromes in the Veterans Administration population.

Komrokji RS, Matacia-Murphy GM, Al Ali NH, Beg MS, Safa MM, Rollison DE, List AF. Komrokji RS, et al. Leuk Res. 2010 Jan;34(1):59-62. doi: 10.1016/j.leukres.2009.03.022. Epub 2009 Apr 14. Leuk Res. 2010. PMID: 19368972

8

Decitabine versus 5-azacitidine for the treatment of myelodysplastic syndrome: adjusted indirect meta-analysis.

Kumar A, List AF, Hozo I, Komrokji R, Djulbegovic B. Kumar A, et al. Haematologica. 2010 Feb;95(2):340-2; author reply 343-4. doi: 10.3324/haematol.2009.017764. Epub 2009 Oct 22. Haematologica. 2010. PMID: 19850902 Free PMC article. No abstract available.

9

Lenalidomide for treatment of myelodysplastic syndromes: current status and future directions.

Komrokji RS, List AF. Komrokji RS, et al. Hematol Oncol Clin North Am. 2010 Apr;24(2):377-88. doi: 10.1016/j.hoc.2010.02.013. Hematol Oncol Clin North Am. 2010. PMID: 20359632 Review.

10

Myelodysplastic syndromes classification and risk stratification.

Komrokji RS, Zhang L, Bennett JM. Komrokji RS, et al. Hematol Oncol Clin North Am. 2010 Apr;24(2):443-57. doi: 10.1016/j.hoc.2010.02.004. Hematol Oncol Clin North Am. 2010. PMID: 20359636 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

378 results

Search Page

Filters